End-of-day quote
Other stock markets
|
||
- EUR | - |
2018 | European shares bounce as trade deal hopes lift risk appetite | RE |
2018 | Huadong Medicine : Sinclair Pharma agrees to potential offer from China's Huadong (Aug 28) | RE |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Miguel Pardos
CEO | Chief Executive Officer | - | 22-05-31 |
Santiago Calavia
PRN | Corporate Officer/Principal | - | - |
Julie Moreau
PRN | Corporate Officer/Principal | - | - |
Kamal Abbasi
PRN | Corporate Officer/Principal | - | - |
Jayne Burrell
LAW | General Counsel | 50 | 15-01-01 |
Nairn McMaster
PRN | Corporate Officer/Principal | - | 11-06-30 |
Emilie Croissant
SAM | Sales & Marketing | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Cheng Wei Liu
CHM | Chairman | 50 | - |
Miguel Pardos
CEO | Chief Executive Officer | - | 22-05-31 |
Gen Li
BRD | Director/Board Member | - | 23-04-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 580,157,084 | 315,849,061 ( 54.44 %) | 0 | 54.44 % |
Company contact information
Sinclair Pharma Ltd.
Whitfield Court 30-32 Whitfield Street
W1T 2RQ, London
+44 20 7467 6920
http://www.sinclairpharma.comSector
1st Jan change | Capi. | |
---|---|---|
+21.98% | 43.92B | |
+24.56% | 23.09B | |
+19.25% | 15.35B | |
+14.03% | 13.61B | |
+46.40% | 12.02B | |
-10.14% | 7B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.88% | 5.6B |
- Stock Market
- Equities
- Stock
- Stock
- Company SINCLAIR IS PHARMA